Clinical Trials Search

Title Sort ascending Intervention Sponsor Status
Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial Biopsy, Biospecimen Collection, Placebo Administration, Urolithin A Supplement National Cancer Institute (NCI) Not yet recruiting
Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors Placebo Administration, Delta-8-Tetrahydrocannabinol, Cannabidiol, Questionnaire Administration City of Hope Medical Center Not yet recruiting
Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens Bazedoxifene and Conjugated Estrogens University of Kansas Medical Center Recruiting
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery Endoxifen Hydrochloride, Questionnaire Administration, Placebo Administration National Cancer Institute (NCI) Active, not recruiting
Pharmacokinetics of Benzo[a]Pyrene: Impact of Diet DIM supplement before 50 ng dose, Brussels sprouts before 50 ng dose, [14C]-benzo[a]pyrene Oregon State University Active, not recruiting
Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer Antitumor B Medical College of Wisconsin Active, not recruiting
Patient-Specific Decision Aid System for Shared Decision Making About Breast Reconstruction Conventional Imaging, Educational Intervention, Enhanced Consultation, Questionnaire Administration, Standard of Care Consultation M.D. Anderson Cancer Center Active, not recruiting
Patient-centered and Efficacious Advance Care Planning in Cancer: the PEACe Comparative Effectiveness Trial Web-based advance care planning, Facilitated advance care planning (in-person or telephonic) University of Pittsburgh Enrolling by invitation
Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer Treatment Enhanced Usual Care, Pathways Laurie McLouth Not yet recruiting
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer Palbociclib, Letrozole, Fulvestrant, Questionnaire Administration, Quality-of-Life Assessment Alliance for Clinical Trials in Oncology Active, not recruiting